Ann: Medical Cannabis Import & Export Licences Secured, page-126

The market is not convinced not because the ann could not be viewed, its not convinced because there is nothing really new in the ann.
The import/export licence was already in place April ann (BHC) and is irrelevant to Canntab until Canntab obtain their own relevant Canadian licensing.
Medcan does not have the manufacture licence and therefore cannot export what it is licensed to cultivate ( when it is able to even cultivate) .. Medcan can only cultivate the amount of cannabis that a licensed manufacturer is contracted to take.
Whilst I would like ,as a holder, nothing more than to see this share price climb, it cannot until the management realise that the price they negotiated for MCL which was based, according to one posters phone call with Sholom, solely on market price and not on any independent assessment/valuation, has been judged by that same market as too high a price.
The CR @ 0.08 is still in doubt
IMO No amount of ann's like the above between now and when QBL goes into suspension again will change that unless there is a radical re- evaluation of the deal/s that better reflects what the market actually thinks of their value.